Cyclacel Pharmaceuticals ... (CYCC)
NASDAQ: CYCC
· Real-Time Price · USD
6.37
-0.40 (-5.91%)
At close: Sep 11, 2025, 3:59 PM
Cyclacel Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
PE Ratio | -66.85 | -22.66 | -84.96 | -441 |
Forward PE Ratio | n/a | n/a | n/a | n/a |
PEG Ratio | 0.70 | -37.99 | 7.58 | -2.9 |
PS Ratio | 17.43K | 1.22K | n/a | n/a |
PB Ratio | -344.75 | 842.04 | 88.14 | 220.97 |
P/FCF Ratio | -93.8 | -31.71 | -86.44 | -448.6 |
P/OCF Ratio | -93.8 | -31.72 | -86.47 | -449.25 |
Price to Fair Value | -344.75 | 842.04 | 88.14 | 220.97 |
Debt / Equity Ratio | n/a | 0.06 | 0.01 | 0.00 |
Debt to Assets Ratio | n/a | 0.00 | 0.00 | 0.00 |
Debt to Capital Ratio | n/a | 0.06 | 0.01 | 0.00 |
LT Debt to Capital Ratio | n/a | n/a | n/a | n/a |
Debt to Market Cap | n/a | n/a | n/a | n/a |
Quick Ratio | 0.59 | 0.91 | 3.25 | 7.46 |
Current Ratio | 0.59 | 0.91 | 3.25 | 7.56 |
Cash Ratio | 0.50 | 0.41 | 2.44 | 6.75 |
Solvency Ratio | -1.79 | -2.75 | -2.78 | -3.46 |
Asset Turnover | 0.01 | 0.05 | n/a | n/a |
Receivables Turnover | 0.18 | 0.14 | n/a | n/a |
Payables Turnover | n/a | n/a | 0.01 | 0.02 |
Inventory Turnover | n/a | n/a | n/a | 0.07 |
Fixed Asset Turnover | 5.38 | 4.12 | n/a | n/a |
Working Capital Turnover | -0.03 | 0.05 | n/a | n/a |
Financial Leverage Ratio | -1.88 | 14.51 | 1.37 | 1.14 |
Interest Coverage | n/a | n/a | n/a | n/a |
Debt Service Coverage | n/a | n/a | n/a | n/a |
Return on Equity | 5.16 | -37.16 | -1.04 | -0.5 |
Return on Assets | -2.74 | -2.56 | -0.76 | -0.44 |
Return on Invested Capital | 5.16 | -34.89 | -1.1 | -0.51 |
OCF Ratio | -1.27 | -1.97 | -2.77 | -3.43 |
OCF/S Ratio | -185.81 | -38.36 | n/a | n/a |
FCF/OCF Ratio | 1.00 | 1.00 | 1.00 | 1.00 |
ST OCF Coverage | n/a | n/a | n/a | n/a |
OCF Coverage Ratio | n/a | -435.46 | -196.48 | -618 |
CapEx Coverage Ratio | n/a | -2.69K | -2.98K | -686.67 |
Dividend & CapEx Coverage | n/a | -77.84 | -100.13 | -81.32 |
Dividend Yield | n/a | 0.00 | 0.00 | 0.00 |
Dividend Yield % | n/a | 0.04 | 0.01 | 0.00 |
Payout Ratio | n/a | -0.01 | -0.01 | -0.01 |
Dividend Per Share | n/a | 0.25 | 0.27 | 0.34 |
Gross Profit Margin | 1.00 | 1.00 | n/a | n/a |
EBIT Margin | -279.16 | -60.6 | n/a | n/a |
EBITDA Margin | -279.02 | -60.53 | n/a | n/a |
Operating Profit Margin | -279.16 | -60.6 | n/a | n/a |
Pretax Profit Margin | -278.93 | -60.84 | n/a | n/a |
Continuous Operations Margin | -260.74 | -53.7 | n/a | n/a |
Net Profit Margin | -260.74 | -53.7 | n/a | n/a |
Bottom Line Profit Margin | -260.74 | -54.18 | n/a | n/a |
FCF Margin | -185.81 | -38.38 | n/a | n/a |
Revenue Per Share | 0.01 | 0.53 | n/a | n/a |
Net Income Per Share | -1.35 | -28.28 | -28.25 | -31.74 |
Interest Debt Per Share | n/a | 0.05 | 0.14 | 0.05 |
Cash Per Share | 0.38 | 4.24 | 24.45 | 61.44 |
Book Value Per Share | -0.26 | 0.76 | 27.23 | 63.34 |
Tangible Book Value Per Share | -0.26 | 0.76 | 27.23 | 63.34 |
Shareholders' Equity Per Share | -0.26 | 0.76 | 27.23 | 63.34 |
Operating Cash Flow Per Share | -0.96 | -20.2 | -27.76 | -31.16 |
CapEx Per Share | n/a | 0.01 | 0.01 | 0.05 |
Free Cash Flow Per Share | -0.96 | -20.21 | -27.76 | -31.2 |
Net Income / EBT | 0.93 | 0.88 | 0.82 | 0.85 |
EBT / EBIT | 1.00 | 1.00 | 0.94 | 0.97 |
Effective Tax Rate | 0.07 | 0.12 | 0.18 | 0.17 |
EV Multiple | -62.21 | -19.97 | -64.53 | -365.46 |
Source: Financial Modeling Prep. Financial Sources.